The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: a randomized clinical trial.

Standard

The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: a randomized clinical trial. / Menter, Alan; Augustin, Matthias; Signorovitch, James; Yu, Andrew P; Wu, Eric Q; Gupta, Shiraz R; Bao, Yanjun; Mulani, Parvez.

in: J AM ACAD DERMATOL, Jahrgang 62, Nr. 5, 5, 2010, S. 812-818.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

APA

Vancouver

Bibtex

@article{54e6564d40384b768366b3b771a3609d,
title = "The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: a randomized clinical trial.",
abstract = "Psoriasis is associated with health-related quality-of-life impairment and depression.",
author = "Alan Menter and Matthias Augustin and James Signorovitch and Yu, {Andrew P} and Wu, {Eric Q} and Gupta, {Shiraz R} and Yanjun Bao and Parvez Mulani",
year = "2010",
language = "Deutsch",
volume = "62",
pages = "812--818",
journal = "J AM ACAD DERMATOL",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "5",

}

RIS

TY - JOUR

T1 - The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: a randomized clinical trial.

AU - Menter, Alan

AU - Augustin, Matthias

AU - Signorovitch, James

AU - Yu, Andrew P

AU - Wu, Eric Q

AU - Gupta, Shiraz R

AU - Bao, Yanjun

AU - Mulani, Parvez

PY - 2010

Y1 - 2010

N2 - Psoriasis is associated with health-related quality-of-life impairment and depression.

AB - Psoriasis is associated with health-related quality-of-life impairment and depression.

M3 - SCORING: Zeitschriftenaufsatz

VL - 62

SP - 812

EP - 818

JO - J AM ACAD DERMATOL

JF - J AM ACAD DERMATOL

SN - 0190-9622

IS - 5

M1 - 5

ER -